Ropinirole versus levodopa in Parkinson's disease.

被引：1
|
作者：
Morgan J.C.
Sethi K.D.
机构：
来源：
Current Neurology and Neuroscience Reports | 2004年 / 4卷 / 4期
关键词：
Levodopa; Selegiline; Pramipexole; Ropinirole; Rotigotine;
D O I：
10.1007/s11910-004-0051-3
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：274 / 276
页数：2
相关论文
共 50 条
  • [31] Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease A 16-week bromocriptine controlled study
    Joo-Hyuk Im
    Jeong-Ho Ha
    In-Sook Cho
    Myoung C. Lee
    Journal of Neurology, 2003, 250 : 90 - 96
  • [32] Levodopa-induced dyskinesias in patients with Parkinson's disease. First national registry of Parkinson's disease: Parkinson en Movimiento
    Arakaki, T.
    Gatto, E.
    Peralta, C.
    Garretto, N.
    Burgos, M.
    Femminini, R.
    Rodriguez, M.
    Zeppa, G.
    Simonetti, D.
    Napoli, G.
    Ziliani, J.
    Rey, R.
    Chade, A.
    Questa Laudanni, M.
    Bauso, D.
    Giannaula, R.
    Merello, M.
    Bueri, J.
    Pelli Noble, F.
    Bestoso, S.
    Suby, E.
    Gershanik, O.
    MOVEMENT DISORDERS, 2011, 26 : S190 - S190
  • [33] Fluctuations in Parkinson's disease. Pathogenetic significance of levodopa's cerebral pharmacokinetics and pharmacodynamics
    Baas, H
    Harder, S
    Demisch, L
    Burklin, F
    Stecker, K
    Fischer, PA
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1995, (46): : 367 - 379
  • [34] Onset of Dyskinesia with Adjunct Ropinirole Prolonged-Release or Additional Levodopa in Early Parkinson's Disease
    Watts, Ray L.
    Lyons, Kelly E.
    Pahwa, Rajesh
    Sethi, Kapil
    Stern, Matthew
    Hauser, Robert A.
    Olanow, Warren
    Gray, Alex M.
    Adams, Bryan
    Earl, Nancy L.
    MOVEMENT DISORDERS, 2010, 25 (07) : 858 - 866
  • [35] Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: Strong study
    Mizuno, Yoshikuni
    Abe, Takashi
    Hasegawa, Kazuko
    Kuno, Sadako
    Kondo, Tomoyoshi
    Yamamoto, Mitsutoshi
    Nakashima, Mitsuyoshi
    Kanazawa, Ichiro
    MOVEMENT DISORDERS, 2007, 22 (13) : 1860 - 1865
  • [36] Subcortical dementia versus bradyphrenia in Parkinson's disease.
    Trullen, JMP
    Modrego, P
    Andre, MLV
    REVUE NEUROLOGIQUE, 1996, 152 (04) : 301 - 302
  • [37] Effects of levodopa on putamenal dopa decarboxylase activity in normal and Parkinson's disease.
    Kuwabara, H
    Shiraishi, M
    Cumming, P
    Jolly, D
    Mzengeza, S
    Porter, D
    Diksic, M
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 213 - 213
  • [38] Assessment of safety and efficacy of Opicapone add-on to levodopa in Parkinson's disease.
    Ruiz-Lopez, Marta
    Diaz, Lola
    Feliz, Cici
    Garcia-Ruiz, Pedro
    NEUROLOGY, 2020, 94 (15)
  • [39] Symptom control in patients with advanced Parkinson's disease: Ropinirole prolonged release versus ropinirole immediate release
    Stocchi, F.
    Giorgi, L.
    Hunter, B.
    Schapira, A. H. N.
    MOVEMENT DISORDERS, 2009, 24 : S281 - S281
  • [40] Levodopa and Parkinson's disease
    Valkovic, P.
    Blazicek, P.
    Benetin, J.
    Kukumberg, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2006, 69 (03) : 183 - 188
12345